Andrew Hykes, President and CEO at Inari Medical, Inc. (NARI), sold 3,000 shares at $55.20 ($166K) on 2024-12-20, disclosed to the SEC on 2024-12-20.
Scheduled sale ($166k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.20 | 2,400 | $132K | 79.9% |
| 2 | $55.65 | 600 | $33K | 20.1% |
| Total | $55.29 avg | 3,000 | $166K | 100% |
| Filing → |
| NARI | SELL | 2024-08-22 | $150K | — | Filing → |
| NARI | SELL | 2024-07-24 | $166K | — | Filing → |
| NARI | SELL | 2024-07-03 | $150K | — | Filing → |